SCHEMBL19267422

SCHEMBL19267422

CCCCN(CC)CCc1ccc(-c2ccc(C(=O)NCC(=O)O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.49
▸ DRD4 P21917 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ RARB P10826 6/20 0.47
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ RARA P10276 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ MTOR P42345 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ TMEM97 Q5BJF2 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ PLK1 P53350 1/20 0.44
▸ MCHR1 Q99705 1/20 0.43
▸ THRA P10827 1/20 0.43
▸ THRB P10828 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15723430 0.85 RARB (0.65) CA1CA2CA9RARBMEN1
SCHEMBL19267247 0.81 RARB (0.45) DRD2DRD4DRD3RARBMEN1
SCHEMBL24835257 0.79 RARB (0.59) DRD2DRD3RARBMEN1ALDH1A1
SCHEMBL8884118 0.78 RARB (0.59) RARBMEN1ALDH1A1RARAMAPT
SCHEMBL9215324 0.78 RARB (0.59) RARBMEN1ALDH1A1RARAMAPT
SCHEMBL23014253 0.74 HDAC6 (0.54) DRD2DRD4DRD3KMT2ATMEM97
SCHEMBL15723432 0.72 RARB (0.61) DRD2DRD4DRD3RARBMEN1
SCHEMBL7215489 0.72 THRA (0.63) DRD2DRD4DRD3ALDH1A1TMEM97
SCHEMBL13760121 0.71 KDM4E (0.62) CA1CA2CA9ALDH1A1MAPT
SCHEMBL9826808 0.71 ALDH1A1 (0.79) CA9ALDH1A1MCHR1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2943473-B1 BIPHENYL-ETHYL-PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS ARENA PHARM INC (US) 2017-08-23 — — EP disclosed
Send feedback